A Randomized, Double-Blind, Placebo-Controlled Trial of Duloxetine for the Treatment of Pain in Patients with Multiple Sclerosis.
Background Patients with multiple sclerosis ( MS) often report neuropathic pain ( NP- MS). The purpose of this study was to assess the efficacy and tolerability of duloxetine as treatment for NP- MS. Methods In this study, 239 adults with NP- MS (duloxetine = 118, placebo = 121) were randomized to d...
| Publicado en: | Pain Practice Vol. 14; no. 8; pp. 732 - 745 |
|---|---|
| Autores principales: | , , , |
| Formato: | research tables/charts randomized controlled trial Journal Article |
| Publicado: |
Wiley-Blackwell
Nov2014
|
| Acceso en línea: | Ver este registro en EBSCOhost |